The Joint Corp.
NASDAQ:JYNTMedical - Care Facilities
+$0.17 today
- Market cap
- $91.03M
- Beta
- 1.10
- P/E (TTM)
- 40.7
- EPS (TTM)
- $0.23
Volume 0.05M
Average 0.07M
JYNT Stock-Based Compensation
Employee pay granted in shares or options; a non-cash expense that dilutes existing shareholders.
The Joint Corp.NASDAQ: JYNT
Stock-Based Compensation · Q1 FY2026 · quarter ended Mar 2026
Stock-based compensation outflow shrinks to $0
Q1 FY2026 stock-based compensation was $0, compared with $293.94K a year earlier. Trailing-twelve-month stock-based compensation was $657.28K. Over 3 fiscal years it compounded at +0.6% a year.
Context
- Stock-based compensation amounted to 2.4% of revenue in FY2025, down 0.9 pp from a year earlier.
- Stock-based compensation increased in 1 of the last 3 fiscal years.
What to watch
Whether quarterly stock-based compensation holds near $0 or moves back toward the trailing-twelve-month quarterly average of $164.32K.
Sources:Cash FlowText generated from reported figures; not investment advice.
Stock-Based Compensation history
USD · from the cash flow
- Latest · FY2025
- 1.3M USD
- Year-over-year change
- -22.7%
- 4-year CAGR
- +5.3%
| Period | Period end | Stock-Based Compensation | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 1.3M | -22.7% |
| FY2024 | 2024-12-31 | 1.68M | -3.4% |
| FY2023 | 2023-12-31 | 1.74M | +36.4% |
| FY2022 | 2022-12-31 | 1.27M | +20.6% |
| FY2021 | 2021-12-31 | 1.06M | — |
Stock-Based Compensation vs competitors
How JYNT compares with its peers on the latest reported figures
- JYNT's LTM Mar 2026 stock-based compensation of $657.28K is the 10th largest of the 11 companies compared; the peer median is $5.62M.
- Its year-over-year change of -55.6% is the 9th highest of 11, against a peer median of -8.0%.
- Stock-based compensation amounts to 1.2% of revenue for JYNT, versus a peer median of 8.8%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $2.3B | +49501.8% | -33.1% | 44751.8% | |
| LTM Mar 2026 | $109.65M | +24888.0% | +373.5% | 27627.6% | |
| LTM Mar 2026 | $18.83M | +85.9% | +222.1% | — | |
| LTM Mar 2026 | $15.84M | +9.4% | +29.4% | 5.2% | |
| LTM Mar 2026 | $6.79M | -25.3% | -52.3% | 3.6% | |
| LTM Mar 2026 | $4.45M | -34.7% | +0.4% | 7810.5% | |
| LTM Mar 2026 | $4.21M | +10.0% | +0.1% | 12.3% | |
| LTM Mar 2026 | $1.83M | -42.1% | -16.4% | — | |
| LTM Mar 2026 | $1.02M | -69.4% | -33.1% | 1.8% | |
| LTM Mar 2026 | $657.28K | -55.6% | +0.6% | 1.2% | |
| LTM Mar 2026 | $67K | -92.8% | -54.8% | 0.1% | |
| Peer median (excluding JYNT) | $5.62M | -8.0% | -8.1% | 8.8% | |
Competitors are the stored peer set for JYNT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 7.57M | 626.71K | (9.75M) | (8.53M) | 2.91M |
| Depreciation & Amortization | 3.92M | 6.65M | 8.58M | 4.72M | 1.71M |
| Deferred Income Tax | (1.78M) | (441.35K) | 10.9M | (55.56K) | 93.07K |
| Stock-Based Compensation | 1.06M | 1.27M | 1.74M | 1.68M | 1.3M |
| Change in Working Capital | 3.09M | (238.06K) | 798.62K | 1.1M | (9.56M) |
| Accounts Receivables | (1.64M) | (154.67K) | 192.35K | (1.65M) | 1.53M |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | (14.37K) | 818.27K | (1.38M) | 68.26K | (391.13K) |
| Other Working Capital | 4.74M | (901.65K) | 1.99M | 2.68M | (10.7M) |
| Other Non-Cash Items | (7.77K) | 341.68K | 2.41M | 10.5M | 5.39M |
| Operating Cash Flow | 13.84M | 8.21M | 14.68M | 9.42M | 1.84M |
| Capital Expenditures | (6.99M) | (5.9M) | (5M) | (1.19M) | (1.5M) |
| Acquisitions (Net) | (5.77M) | (12.11M) | (1.19M) | 554.1K | 7.78M |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 105.2K | 0 | 0 | 0 |
| Investing Cash Flow | (12.75M) | (17.9M) | (6.19M) | (631.55K) | 6.27M |
| Debt Repayment | (2.81M) | (49.86K) | (24.43K) | (2.03M) | (4.35K) |
| Common Stock Issued | 0 | 0 | 202.39K | 33.71K | 1.52M |
| Common Stock Repurchased | 0 | (5.8K) | (3.83K) | (9.58K) | (11.32M) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 811.59K | 384.27K | 0 | 0 | 0 |
| Financing Cash Flow | (2M) | 328.61K | 174.12K | (2M) | (9.81M) |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | (907.29K) | (9.36M) | 8.66M | 6.78M | (1.69M) |
| Free Cash Flow | 6.85M | 2.31M | 9.68M | 8.23M | 334.72K |
The Joint Corp.
NASDAQ:JYNT
Intrinsic Alpha fair value
Locked
Current Price
$6.65
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.